#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate Expression in Breast Cancer Cells


Peptidylarginine deiminase IV (PADI4) catalyzes the conversion of positively charged arginine and methylarginine residues to neutrally charged citrulline, and this activity has been linked to the repression of a limited number of target genes. To broaden our knowledge of the regulatory potential of PADI4, we utilized chromatin immunoprecipitation coupled with promoter tiling array (ChIP-chip) analysis to more comprehensively investigate the range of PADI4 target genes across the genome in MCF-7 breast cancer cells. Results showed that PADI4 is enriched in gene promoter regions near transcription start sites (TSSs); and, surprisingly, this pattern of binding is primarily associated with actively transcribed genes. Computational analysis found potential binding sites for Elk-1, a member of the ETS oncogene family, to be highly enriched around PADI4 binding sites; and coimmunoprecipitation analysis then confirmed that Elk-1 physically associates with PADI4. To better understand how PADI4 may facilitate gene transactivation, we then show that PADI4 interacts with Elk-1 at the c-Fos promoter and that, following Epidermal Growth Factor (EGF) stimulation, PADI4 catalytic activity facilitates Elk-1 phosphorylation, histone H4 acetylation, and c-Fos transcriptional activation. These results define a novel role for PADI4 as a transcription factor co-activator.


Vyšlo v časopise: Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate Expression in Breast Cancer Cells. PLoS Genet 7(6): e32767. doi:10.1371/journal.pgen.1002112
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002112

Souhrn

Peptidylarginine deiminase IV (PADI4) catalyzes the conversion of positively charged arginine and methylarginine residues to neutrally charged citrulline, and this activity has been linked to the repression of a limited number of target genes. To broaden our knowledge of the regulatory potential of PADI4, we utilized chromatin immunoprecipitation coupled with promoter tiling array (ChIP-chip) analysis to more comprehensively investigate the range of PADI4 target genes across the genome in MCF-7 breast cancer cells. Results showed that PADI4 is enriched in gene promoter regions near transcription start sites (TSSs); and, surprisingly, this pattern of binding is primarily associated with actively transcribed genes. Computational analysis found potential binding sites for Elk-1, a member of the ETS oncogene family, to be highly enriched around PADI4 binding sites; and coimmunoprecipitation analysis then confirmed that Elk-1 physically associates with PADI4. To better understand how PADI4 may facilitate gene transactivation, we then show that PADI4 interacts with Elk-1 at the c-Fos promoter and that, following Epidermal Growth Factor (EGF) stimulation, PADI4 catalytic activity facilitates Elk-1 phosphorylation, histone H4 acetylation, and c-Fos transcriptional activation. These results define a novel role for PADI4 as a transcription factor co-activator.


Zdroje

1. HipskindRARaoVNMuellerCGReddyESNordheimA 1991 Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354 531 534

2. TreismanR 1990 The SRE: a growth factor responsive transcriptional regulator. Semin Cancer Biol 1 47 58

3. HillCSWynneJTreismanR 1994 Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J 13 5421 5432

4. HillCSTreismanR 1995 Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80 199 211

5. PriceMARogersAETreismanR 1995 Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J 14 2589 2601

6. LiaoJHodgeCMeyerDHoPSRosenspireK 1997 Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element. J Biol Chem 272 25951 25958

7. TreismanR 1985 Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell 42 889 902

8. GilleHKortenjannMThomaeOMoomawCSlaughterC 1995 ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14 951 962

9. LiQJYangSHMaedaYSladekFMSharrocksAD 2003 MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. EMBO J 22 281 291

10. JanknechtRErnstWHPingoudVNordheimA 1993 Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J 12 5097 5104

11. HodgeCLiaoJStofegaMGuanKCarter-SuC 1998 Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 273 31327 31336

12. LiBCareyMWorkmanJL 2007 The role of chromatin during transcription. Cell 128 707 719

13. KouzaridesT 2007 Chromatin modifications and their function. Cell 128 693 705

14. O'DonnellAYangSHSharrocksAD 2008 MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch. Mol Cell 29 780 785

15. HagiwaraTNakashimaKHiranoHSenshuTYamadaM 2002 Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 290 979 983

16. CuthbertGLDaujatSSnowdenAWErdjument-BromageHHagiwaraT 2004 Histone deimination antagonizes arginine methylation. Cell 118 545 553

17. WangYWysockaJSayeghJLeeYHPerlinJR 2004 Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306 279 283

18. DenisHDeplusRPutmansPYamadaMMétivierR 2009 Functional connection between deimination and deacetylation of histones. Mol Cell Biol 29 4982 4993

19. LiPYaoHZhangZLiMLuoY 2008 Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol 28 4745 4758

20. YaoHLiPVentersBJZhengSThompsonPR 2008 Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem 283 20060 20068

21. GambleMJFrizzellKMYangCKrishnakumarRKrausWL 2010 The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev 24 21 32

22. CarrollJSMeyerCASongJLiWGeistlingerTR 2006 Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38 1289 1297

23. KininisMChenBSDiehlAGIsaacsGDZhangT 2007 Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol 27 5090 5104

24. XuXBiedaMJinVXRabinovichAOberleyMJ 2007 A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 17 1550 1561

25. RabinovichAJinVXRabinovichRXuXFarnhamPJ 2008 E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites. Genome Res 18 1763 1777

26. KrishnakumarRGambleMJFrizzellKMBerrocalJGKininisM 2008 Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319 819 821

27. GévryNHardySJacquesPELaflammeLSvotelisA 2009 Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev 23 1522 1533

28. LachnerMO'SullivanRJJenuweinT 2003 An epigenetic road map for histone lysine methylation. J Cell Sci 116 2117 2124

29. KomashkoVMAcevedoLGSquazzoSLIyengarSSRabinovichA 2008 Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res 18 521 532

30. HollenhorstPCShahAAHopkinsCGravesBJ 2007 Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 21 1882 1894

31. HollenhorstPCChandlerKJPoulsenRLJohnsonWESpeckNA 2009 DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet 5 e1000778 doi:10.1371/journal.pgen.1000778

32. CollinsPJKobayashiYNguyenLTrinkleinNDMyersRM 2007 The ets-related transcription factor GABP directs bidirectional transcription. PLoS Genet 3 e208 doi:10.1371/journal.pgen.0030208

33. BorosJDonaldsonIJO'DonnellAOdrowazZAZeefL 2009 Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 19 1963 1973

34. TreismanRMaraisRWynneJ 1992 Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J 11 4631 4640

35. WildingGLippmanMEGelmannEP 1988 Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res 48 802 805

36. LuoYAritaKBhatiaMKnuckleyBLeeYH 2006 Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45 11727 11736

37. LiQVaingankarSMGreenHMMartins-GreenM 1999 Activation of the 9E3/cCAF chemokine by phorbol esters occurs via multiple signal transduction pathways that converge to MEK1/ERK2 and activate the Elk1 transcription factor. J Biol Chem 274 15454 15465

38. SenshuTSatoTInoueTAkiyamaKAsagaH 1992 Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 203 94 100

39. StuartETGrussP 1996 PAX: developmental control genes in cell growth and differentiation. Cell Growth Differ 7 405 412

40. Delannoy-CourdentAMattotVFafeurVFauquetteWPolletI 1998 The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 111 1521 1534

41. LevyDEGillilandDG 2000 Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 19 2505 2510

42. ZhangSYLiuSCAl-SaleemLFHolloranDBabbJ 2000 E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 9 395 401

43. ClevengerCV 2004 Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 165 1449 1460

44. RobsonEJHeSJEcclesMR 2006 A PANorama of PAX genes in cancer and development. Nat Rev Cancer 6 52 62

45. LeeYHCoonrodSAKrausWLJelinekMAStallcupMR 2005 Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc Natl Acad Sci USA 102 3611 3616

46. VanhouttePNissenJLBruggBGasperaBDBessonMJ 2001 Opposing roles of Elk-1 and its brain-specific isoform, short Elk-1, in nerve growth factor-induced PC12 differentiation. J Biol Chem 276 5189 5196

47. R Development Core Team 2006 R. A language and environment for statistical computing. In. R Foundation for Statistical Computing, Vienna, Austria

48. SmythGKSpeedT 2003 Normalization of cDNA microarray data. Methods 31 265 273

49. SaldanhaAJ 2004 Java Treeview–extensible visualization of microarray data. Bioinformatics 20 3246 3248

50. KarolchikDHinrichsASFureyTSRoskinKMSugnetCW 2004 The UCSC Table Browser data retrieval tool. Nucleic Acids Res 32 493 496

51. KuhnRMKarolchikDZweigASWangTSmithKE 2009 The UCSC Genome Browser Database: update 2009. Nucleic Acids Res 37 755 761

52. BembomO 2008 seqLogo: Sequence logos for DNA sequence alignments. R package version 1.12.0

53. DennisGJrShermanBTHosackDAYangJGaoW 2003 DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 P3

54. HuangDWShermanBTLempickiRA 2009 Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 4 44 57

55. RobersonMSZhangTLiHLMulvaneyJM 1999 Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone. Endocrinology 140 1310 1318

56. RobersonMSBanMZhangTMulvaneyJM 2000 Role of the cyclic AMP response element binding complex and activation of mitogen-activated protein kinases in synergistic activation of the glycoprotein hormone alpha subunit gene by epidermal growth factor and forskolin. Mol Cell Biol 20 3331 3344

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2011 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#